The estimated Net Worth of Dennis Helling is at least $593 mil dollars as of 4 March 2022. Dennis Helling owns over 5,000 units of Tabula Rasa HealthCare Inc stock worth over $369,096 and over the last 7 years he sold TRHC stock worth over $0. In addition, he makes $223,625 as Independent Director at Tabula Rasa HealthCare Inc.
Dennis has made over 9 trades of the Tabula Rasa HealthCare Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he bought 5,000 units of TRHC stock worth $30,850 on 4 March 2022.
The largest trade he's ever made was buying 7,194 units of Tabula Rasa HealthCare Inc stock on 10 November 2021 worth over $99,709. On average, Dennis trades about 2,360 units every 45 days since 2017. As of 4 March 2022 he still owns at least 35,152 units of Tabula Rasa HealthCare Inc stock.
You can see the complete history of Dennis Helling stock trades at the bottom of the page.
Dr. Dennis K. Helling serves as Independent Director of the Company. Dr. Helling has been a Clinical Professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences since 1992. From 1992 until January 2013, Dr. Helling served as the Executive Director of Pharmacy Operations and Therapeutics at Kaiser Permanente Colorado, a nonprofit health maintenance organization that develops innovative pharmacy services. In 1979, Dr. Helling co-founded the American College of Clinical Pharmacy, an international association of clinical pharmacists dedicated to optimizing drug therapy outcomes in patients, and served as President from 1997 through 1998. Dr. Helling also served as President of the Accreditation Council for Pharmacy Education, a national agency responsible for the accreditation of professional degree programs in pharmacy, from 2002 through 2004 and the American Pharmacists Association Foundation, a nonprofit organization whose mission is to improve health by inspiring philanthropy, research, and innovation that advances pharmacists’ patient care services, from 2010 through 2012. Over his career, Dr. Helling has been actively involved in hospice and palliative care, serving on the boards of Care Synergy since 2015 and as Vice-Chair of The Denver Hospice Board of Directors since 2009. Dr. Helling has also chaired the Working Group on Pharmacy Reimbursement in the Federation of International Pharmacy. Dr. Helling currently serves on the American Pharmacists Association Board of Trustees and Pharmacy Specialties Board of Directors. Dr. Helling earned a BSPharm from the St. Louis College of Pharmacy, a PharmD from the University of Cincinnati College of Pharmacy and completed his residency at Cincinnati General Hospital. Dr. Helling was awarded the highest national honor in pharmacy, the Remington Honor Medal, in 2013.
As the Independent Director of Tabula Rasa HealthCare Inc, the total compensation of Dennis Helling at Tabula Rasa HealthCare Inc is $223,625. There are 10 executives at Tabula Rasa HealthCare Inc getting paid more, with Calvin Knowlton having the highest compensation of $5,135,730.
Dennis Helling is 71, he's been the Independent Director of Tabula Rasa HealthCare Inc since 2017. There are 1 older and 15 younger executives at Tabula Rasa HealthCare Inc. The oldest executive at Tabula Rasa HealthCare Inc is A. Gordon Tunstall, 76, who is the Lead Independent Director.
Dennis's mailing address filed with the SEC is 228 STRAWBRIDGE DRIVE, SUITE 100, MOORESTOWN, NJ, 08057.
Over the last 8 years, insiders at Tabula Rasa HealthCare Inc have traded over $245,667,405 worth of Tabula Rasa HealthCare Inc stock and bought 1,486,398 units worth $7,620,320 . The most active insiders traders include Calvin H Knowlton, Orsula V Knowlton, eCapital Management, L.P.Ic .... On average, Tabula Rasa HealthCare Inc executives and independent directors trade stock every 8 days with the average trade being worth of $441,116. The most recent stock trade was executed by Michael Greenhalgh on 28 June 2023, trading 25,000 units of TRHC stock currently worth $77,750.
the tabula rasa healthcare family of companies provide new beginnings for our clients, through innovative service models and fresh approaches to healthcare technology. our leaders understand that to maximize patient experiences and outcomes, they must help providers to balance efficiency and scalability with safety and individualization of care.
Tabula Rasa HealthCare Inc executives and other stock owners filed with the SEC include: